Physician profile
Michael G Maline
NPI 1801075759
$5,670.27
in general payments reported to CMS, 2019-2025
17 companies · $3,290 in 2025
The $3,290 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,642 · 2020: $173 · 2021: $259 · 2022: $77.97 · 2023: $148 · 2024: $80.80 · 2025: $3,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,364 · Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,363.58 |
| Food and Beverage | $1,155.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,183.54 | 2024-2025 | Persona, Rosa |
| Medacta USA, INC. | $1,155.76 | 2019 | |
| Stryker Corporation | $450.73 | 2019-2025 | Gamma |
| Sanofi-Aventis U.S. LLC | $125.88 | 2020-2023 | |
| Bioventus LLC | $119.83 | 2019-2025 | Durolane |
| Pacira Therapeutics, INC. | $118.23 | 2019-2021 | |
| Smith+Nephew, INC. | $98.22 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $75.61 | 2022-2023 | Seglentis |
| Horizon Therapeutics Plc | $72.55 | 2019-2022 | |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Avanos Medical | $62.39 | 2019-2020 | |
| Djo, LLC | $43.27 | 2024 | Cmf |
| Solventum Corporation | $24.15 | 2025 | V.A.C.Ulta |
| Dynasplint Systems INC. | $20.99 | 2020 | |
| Baudax Bio INC. | $19.78 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $17.60 | 2021 | |
| Depuy Synthes Sales INC. | $16.00 | 2025 | Tfn-Advance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.